Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

OBJECTIVE: The inflammatory cytokine interleukin-6 (IL-6) is associated with cardiovascular (CV) and kidney outcomes in various populations. However, data in patients with type 2 diabetes are limited. We assessed the association of IL-6 with CV and kidney outcomes in the Canagliflozin Cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshino, Akihiko, Schechter, Meir, Sen, Taha, Vart, Priya, Neuen, Brendon L., Neal, Bruce, Arnott, Clare, Perkovic, Vlado, Ridker, Paul M., Tuttle, Katherine R., Hansen, Michael K., Heerspink, Hiddo J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862371/
https://www.ncbi.nlm.nih.gov/pubmed/36134918
http://dx.doi.org/10.2337/dc22-0866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862371/
https://www.ncbi.nlm.nih.gov/pubmed/36134918
http://dx.doi.org/10.2337/dc22-0866

Ejemplares similares